Orange Book product · Generic (ANDA)
TIMOLOL MALEATE
TIMOLOL MALEATE
At a glance
Aug 07, 2024
Approved
Generic (ANDA)
Application
AT1
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 07, 2024
1 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
TIMOLOL MALEATE
Strength
EQ 0.5% BASE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT1
Application
ANDA 218460
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TIMOLOL MALEATE
- 2004ISTALOLBrand (NDA)
NDA 021516 · BAUSCH AND LOMB
- 1998TIMOLOL MALEATEBrand (NDA)
NDA 020963 · SANDOZ
- 1993TIMOPTIC-XEBrand (NDA)
NDA 020330 · BAUSCH AND LOMB INC
- 1986TIMOPTIC IN OCUDOSEBrand (NDA)
NDA 019463 · BAUSCH AND LOMB INC
- —TIMOPTICBrand (NDA)
NDA 018086 · BAUSCH AND LOMB INC
- —BLOCADRENBrand (NDA)
NDA 018017 · MERCK
- 2024TIMOLOL MALEATEGeneric (ANDA)
ANDA 210640 · SOMERSET THERAPS LLC
- 2024TIMOLOL MALEATEGeneric (ANDA)
ANDA 217764 · SOMERSET
- 2024TIMOLOL MALEATEGeneric (ANDA)
ANDA 216653 · SOMERSET THERAPS LLC
- 2024TIMOLOL MALEATEGeneric (ANDA)
ANDA 216343 · AMNEAL
- 2023TIMOLOL MALEATEGeneric (ANDA)
ANDA 217343 · MICRO LABS
- 2023TIMOLOL MALEATEGeneric (ANDA)
ANDA 217195 · SENTISS PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
